Hemostasis and Beyond: The Diverse Functions of Protein S in Controlling Coagulation, Inflammation, and Cancer

Protein S (ProS) is a vitamin K-dependent glycoprotein that was first described as an anticoagulant cofactor for activated protein C (APC). Since its initial discovery, studies of ProS have revealed an array of functions, spanning coagulation and inflammation, including in the context of cancer. ProS is now known to inhibit all three coagulation complexes—through interactions with APC, tissue factor pathway inhibitor, and activated factor IX—and to have its anticoagulant activity modulated by multiple other plasma proteins. Beyond hemostasis, ProS also participates in complement regulation, through its interaction with complement component C4b-binding protein, and regulates inflammatory cell phenotype and function, through Tyro3 and Mer-Tyrosine Kinase, receptors which mediate efferocytosis, inflammatory resolution, and tissue repair. Emerging evidence further implicates ProS in cancer biology, where its effects are context-dependent and may either support or suppress tumor progression. In this review, we highlight these many functions of ProS and discuss their mechanistic commonalities. Collectively, these functions position ProS as a central regulatory node, with critical roles in physiology and disease.

Authors

Institutions

Publication Details

Journal
International Journal of Molecular Sciences
Published
2026-11-06
DOI
https://doi.org/10.3390/ijms27219932
Primary Topic
Blood Coagulation and Thrombosis Mechanisms
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Hemostasis and Beyond: The Diverse Functions of Protein S in Controlling Coagulation, Inflammation, and Cancer

Jeremy P. Wood, Narges Mehrpour-Karmakan, Mélissa E. Jauquet
1 links
International Journal of Molecular Sciences
Blood Coagulation and Thrombosis Mechanisms
article

Hemostasis and Beyond: The Diverse Functions of Protein S in Controlling Coagulation, Inflammation, and Cancer

Jeremy P. Wood, Narges Mehrpour-Karmakan, Mélissa E. Jauquet
article en

Abstract

Protein S (ProS) is a vitamin K-dependent glycoprotein that was first described as an anticoagulant cofactor for activated protein C (APC). Since its initial discovery, studies of ProS have revealed an array of functions, spanning coagulation and inflammation, including in the context of cancer. ProS is now known to inhibit all three coagulation complexes—through interactions with APC, tissue factor pathway inhibitor, and activated factor IX—and to have its anticoagulant activity modulated by multiple other plasma proteins. Beyond hemostasis, ProS also participates in complement regulation, through its interaction with complement component C4b-binding protein, and regulates inflammatory cell phenotype and function, through Tyro3 and Mer-Tyrosine Kinase, receptors which mediate efferocytosis, inflammatory resolution, and tissue repair. Emerging evidence further implicates ProS in cancer biology, where its effects are context-dependent and may either support or suppress tumor progression. In this review, we highlight these many functions of ProS and discuss their mechanistic commonalities. Collectively, these functions position ProS as a central regulatory node, with critical roles in physiology and disease.

International Journal of Molecular SciencesVol. 27(21)
Texas A&M University – Kingsville (US)
National Heart, Lung, and Blood Institute
Good health and well-being
Openalex Percentile: Top 13%
Blood Coagulation and Thrombosis Mechanisms
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon